je.st
news
Gilead: Your Biggest Consideration
2016-03-14 06:47:01| Biotech - Topix.net
The EBITDA to EV ratio has been growing for two straight years, nearly doubling from 44% to 72%, showing increasing momentum in the company. Late last month, I exited my long position on Gilead .
Tags: consideration
biggest
gilead
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||